CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Study RGX-104-001 is a Phase 1, first-in-human, dose escalation and expansion study of RGX-104, an oral small molecule targeting the liver X receptor...
Phase 1
Louisville, Kentucky, United States of America and 20 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Louisville, Kentucky, United States and 202 other locations
The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...
Phase 3
Louisville, Kentucky, United States and 230 other locations
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase...
Phase 1
Louisville, Kentucky, United States and 39 other locations
The purpose of the trial is to evaluate the safety of acasunlimab (also known as GEN1046) as monotherapy and in combination therapies in patients wit...
Phase 1, Phase 2
Louisville, Kentucky, United States and 56 other locations
Determine the safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of VIP152 (BAY 1251152) as mon...
Phase 1
Louisville, Kentucky, United States and 15 other locations
Clinical trials
Research sites
Resources
Legal